Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The contribution of animal models to understanding the role of the immune system in human idiopathic pulmonary fibrosis
Tylah Miles, Gerard F. Hoyne, Darryl A. Knight, et al.
Clinical & Translational Immunology (2020) Vol. 9, Iss. 7
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Animal Models for the Study of Human Disease
Sherry J. Morgan, Julie A. Hutt, Radhakrishna Sura
(2023), pp. 241-264
Closed Access | Times Cited: 67
Effect of 2D and 3D Culture Microenvironments on Mesenchymal Stem Cell-Derived Extracellular Vesicles Potencies
Gina D. Kusuma, Anqi Li, Dandan Zhu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 56
Environmental Causes of Idiopathic Pulmonary Fibrosis
Sheiphali A. Gandhi, Roberto Tonelli, Margaret Murray, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16481-16481
Open Access | Times Cited: 22
Animals in Respiratory Research
Eleonore Fröhlich
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2903-2903
Open Access | Times Cited: 14
The mitigating effect of para‐hydroxycinnamic acid in bleomycin‐induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways
Zeena Ayad Hussein, Ahmed R. Abu‐Raghif, Hayder Adnan Fawzi
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 23-42
Closed Access | Times Cited: 14
PTX3 Regulation of Inflammation, Hemostatic Response, Tissue Repair, and Resolution of Fibrosis Favors a Role in Limiting Idiopathic Pulmonary Fibrosis
Andrea Doni, Alberto Mantovani, Barbara Bottazzi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 41
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Vaishali Singh, Ilya V. Ulasov, Sachin Gupta, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 22-22
Open Access | Times Cited: 5
“Idiopathic” adhesive capsulitis is caused by reactivation of latent neurotrophic virus involving peripheral nerves around the shoulder capsule: A hypothesis
Wei Xia, R Risco Cortés, Kuen Chin, et al.
Medical Hypotheses (2025), pp. 111604-111604
Closed Access
Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases
Maya Ezzo, Boris Hinz
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108528-108528
Closed Access | Times Cited: 12
Radioproteomics stratifies molecular response to antifibrotic treatment in pulmonary fibrosis
David Lauer, C. Magnin, Luca R. Kolly, et al.
JCI Insight (2024) Vol. 9, Iss. 15
Open Access | Times Cited: 4
GLP-1R activation attenuates the progression of pulmonary fibrosis via disrupting NLRP3 inflammasome/PFKFB3-driven glycolysis interaction and histone lactylation
Chenyang Liu, Qun Zhang, Hong Zhou, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats
Yifeng Luo, Hui Yi, Xinyan Huang, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 321, Iss. 1, pp. L6-L16
Closed Access | Times Cited: 19
Acute exacerbation of idiopathic pulmonary fibrosis model in the rats using bleomycin and lipopolysaccharides
Sandy Vitria Kurniawan, Melva Louisa, Jamal Zaini, et al.
Journal of Advanced Veterinary and Animal Research (2023) Vol. 10, Iss. 2, pp. 196-196
Open Access | Times Cited: 7
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
Muttanagouda Giriyappagoudar, Basavaraj Vastrad, Rajeshwari Horakeri, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3109-3109
Open Access | Times Cited: 7
Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis
Fan Yang, Qinqin Zhang, Xi Wang, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 2
Comparing species-different responses in pulmonary fibrosis research: Current understanding of in vitro lung cell models and nanomaterials
Sandeep Keshavan, Anne Bannuscher, Barbara Drašler, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 183, pp. 106387-106387
Open Access | Times Cited: 6
The normal and fibrotic mouse lung classified by spatial proteomic analysis
Roberta Ciccimarra, Maddalena M. Bolognesi, M. Zoboli, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
I‐Chen Chen, Yi‐Ching Liu, Yen-Hsien Wu, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1543-1543
Open Access | Times Cited: 8
Betulin and Crinum asiaticum L. bulbs extract attenuate pulmonary fibrosis by down regulating pro-fibrotic and pro-inflammatory cytokines in bleomycin-induced fibrosis mice model
Michael Ofori, Cynthia Amaning Danquah, Joshua Asante, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16914-e16914
Open Access | Times Cited: 4
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes
Martina Bonatti, Vanessa Pitozzi, Paola Caruso, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001476-e001476
Open Access | Times Cited: 4
Radioproteomics stratifies molecular response to antifibrotic treatment in pulmonary fibrosis
David Lauer, C. Magnin, Luca R. Kolly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies
Matthew Moll, Brian D. Hobbs, Aravind Menon, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Role of Immune Cells in the Initiation and Progression of Pulmonary Fibrosis
Syamala Soumyakrishnan, Joseph Ayariga, Meenakshisundaram Sreepriya, et al.
Critical Reviews in Immunology (2022) Vol. 42, Iss. 5, pp. 21-41
Closed Access | Times Cited: 3
Sleep Apnea in Idiopathic Pulmonary Fibrosis: A Molecular Investigation in an Experimental Model of Fibrosis and Intermittent Hypoxia
Liasmine Haine, Juliette Bravais, Céline-Hivda Yegen, et al.
Life (2021) Vol. 11, Iss. 9, pp. 973-973
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top